RAP 0.00% 20.5¢ resapp health limited

What's a fair offer from Pfizer?, page-24

  1. 1,171 Posts.
    lightbulb Created with Sketch. 110
    Hi Moodyinvest

    If ResApp was a mature company earning predictable revenue, what you state would make sense. I am a long term holder. I bought in when there was no immediate prospect of revenue. Just as we get to the start of the revenue stage we get the rug pulled out from beneath our feet. Management have been talking about a huge growth in ResApps usage since the last quarterly - surely its prudent to wait a few quarters before recommending any takeover? They have also been talking about a number of different telehealth companies coming on board.

    What the Scheme of Arrangement indicates to me though, is that the board have no faith in management being able to commercialise the product.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.